Effect of rituximab on the incidence of GVHD in lymphoma patients who received the BEAM-conditioning and an allogeneic stem cell transplantation.

被引：0
|
作者：
Khouri, IF [1 ]
Saliba, RM [1 ]
Couriel, DR [1 ]
Okoroji, GJ [1 ]
Acholonu, S [1 ]
Maadani, F [1 ]
Champlin, RE [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4980
引用
收藏
页码：326B / 326B
页数：1
相关论文
共 50 条
  • [1] Bortezomib and BEAM-Rituximab Reduced-Intensity Conditioning for High-Risk Lymphoma Patients Who Are Not Eligible for Nonmyeloablative Allogeneic Stem Cell Transplantation
    Khouri, Issa F.
    Rima, Saliba M.
    Turturro, Francesco
    Korbling, Martin
    Ledesma, Celina
    Rondon, Gabriela
    Alousi, Amin M.
    Anderlini, Paolo
    Bashir, Qaiser
    Ciurea, Stefan O.
    Hosing, Chitra M.
    Popat, Uday R.
    Charafeddine, Yasmeen
    Oki, Yasuhiro
    Fayad, Luis E.
    Champlin, Richard E.
    BLOOD, 2012, 120 (21)
  • [2] Soluble CD30 can distinguish disease progression from acute GVHD in patients with adult T cell leukemia/lymphoma who received allogeneic hematopoietic stem cell transplantation.
    Yoshimitsu, Makoto
    Fujiwara, Hiroshi
    Aoki, Noriko
    Ozaki, Atsuo
    Hamada, Heiichiro
    Matsushita, Kakushi
    Arima, Naomichi
    Tei, Chuwa
    BLOOD, 2006, 108 (11) : 184B - 184B
  • [3] Bortezomib, rituximab, and risk of graft-versus-host disease (GVHD) after BEAM conditioning for allogeneic stem cell transplantation (alloSCT).
    Chamoun, Kamal
    Gulbis, Alison M.
    Milton, Denai
    Jabbour, Elias
    Turturro, Francesco
    Khouri, Issa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma
    Friend, Brian D.
    Muhsen, Ibrahim N.
    Patel, Shreeya
    Hill, LaQuisa C.
    Lulla, Premal
    Ramos, Carlos A.
    Pingali, S. Ravi
    Kamble, Rammurti T.
    John, Tami D.
    Salem, Baheyeldin
    Bhar, Saleh
    Doherty, Erin E.
    Craddock, John
    Sasa, Ghadir
    Wu, Mengfen
    Wang, Tao
    Martinez, Caridad
    Krance, Robert A.
    Heslop, Helen E.
    Carrum, George
    BONE MARROW TRANSPLANTATION, 2022, 57 (04) : 579 - 585
  • [5] Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma
    Brian D. Friend
    Ibrahim N. Muhsen
    Shreeya Patel
    LaQuisa C. Hill
    Premal Lulla
    Carlos A. Ramos
    S. Ravi Pingali
    Rammurti T. Kamble
    Tami D. John
    Baheyeldin Salem
    Saleh Bhar
    Erin E. Doherty
    John Craddock
    Ghadir Sasa
    Mengfen Wu
    Tao Wang
    Caridad Martinez
    Robert A. Krance
    Helen E. Heslop
    George Carrum
    Bone Marrow Transplantation, 2022, 57 : 579 - 585
  • [6] Influence of the Intensity of the Conditioning Regimens on the Risks of Gvhd in Patients Receiving Rituximab Prophylaxis during Allogeneic Stem Cell Transplantation (alloSCT)
    Khouri, Issa F.
    Milton, Denai R.
    Ledesma, Celina
    Jabbour, Elias J.
    Alatrash, Gheath
    Anderlini, Paolo
    Alousi, Amin M.
    Bashir, Qaiser
    Ciurea, Stefan O.
    Hymes, Sharon
    Marin, David
    Molldrem, Jeffrey J.
    Olson, Amanda L.
    Oran, Betul
    Popat, Uday
    Qazilbash, Muzaffar H.
    Rondon, Gabriela
    Champlin, Richard E.
    Gulbis, Alison
    BLOOD, 2018, 132
  • [7] High-dose rituximab in the conditioning regimen before allogeneic stem cell transplantation for relapsed lymphomas: protective role of the antibody on GvHD incidence
    Corradini, P.
    Sarina, B.
    Carniti, C.
    Patriarca, F.
    Carella, A.
    Levis, A.
    Bosi, A.
    Falda, M.
    Di Bartolomeo, P.
    Olivares, C.
    Gimondi, S.
    Rambaldi, A.
    Dodero, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S421 - S421
  • [8] Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab
    Fujimoto, Ayumi
    Hiramoto, Nobuhiro
    Yamasaki, Satoshi
    Inamoto, Yoshihiro
    Ogata, Masao
    Sugio, Yasuhiro
    Fukuda, Takahiro
    Uchida, Naoyuki
    Ikegame, Kazuhiro
    Matsuoka, Ken-ichi
    Shiratori, Souichi
    Kondo, Tadakazu
    Miyamoto, Toshihiro
    Eto, Tetsuya
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Suzuki, Ritsuro
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (02) : 146 - 152
  • [9] High-Dose Rituximab In The Conditioning Regimen Before Allogeneic Stem Cell Transplantation Decreases Deaths Related To Gvhd Without Affecting The Anti-Lymphoma Effect
    Dodero, Anna
    Spina, Francesco
    Sarina, Barbara
    Carniti, Cristiana
    Patriarca, Francesca
    Garella, Angelo Michele
    Levis, Alessandro
    Bosi, Alberto
    Falda, Michele
    Di Bartolomeo, Paolo
    Onida, Francesco
    Dalto, Serena
    Vendramin, Antonio
    Rambaldi, Alessandro
    Corradini, Paolo
    BLOOD, 2013, 122 (21)
  • [10] Cure of adult T-cell leukemia/lymphoma by allogeneic stem cell transplantation with reduced conditioning intensity - End results for the patients who received prospective trials
    Choi, I.
    Utsunomiya, A.
    Tanosaki, R.
    Suehiro, Y.
    Kannagi, M.
    Okamura, J.
    Uike, N.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S658 - S658
12345